2023, Vol. 4, Issue 2, Part A
Comparative study of selected pharmaceutical companies in India during pre and in times of COVID-19
Author(s): Tonoy Dey and Sudipto Mondal
Abstract: The breakout of Coronavirus has had a major impact on the world's economy, with the global growth shrinking to -3.1% in 2020. In India, the GDP growth (inflation adjusted) went in negative figure of -6.60%, causing supply side bottlenecks and weak demand; almost all the industries faced a tough time. This paper attempted to analyze the financial performance of selected Indian Pharmaceutical companies representing the industry with regard to profitability ratios during pre-pandemic period Vs. in times of COVID-19 pandemic since the demand for the products offered by pharma companies soared to a massive height. It was found that on an average, the companies were profitable during the COVID-19 times. By applying statistical testing, it was found that there was no significant difference in the financial performance during both the periods. Hence, the profitability of the sector was unaffected due to the pandemic; in fact, during COVID-19 time, the sector reported better performance.JEL Classification: G32, L190, M410, M49
Pages: 51-61 | Views: 72 | Downloads: 20
Download Full Article: Click Here
How to cite this article:
Tonoy Dey, Sudipto Mondal. Comparative study of selected pharmaceutical companies in India during pre and in times of COVID-19. Asian J Manage Commerce 2023;4(2):51-61.